The event featured Abit Bekzhigit, Director of the Department of International Cooperation, Marketing, and Promotion at JSC National Holding QazBioPharm, who presented to the Congress participants the medical and veterinary products produced by the Holding’s subsidiary organizations.

Representatives of the Holding’s subsidiaries – LLP OtarBioPharm, LLP Kazakh Research Veterinary Institute, and JSC Scientific Center for Anti-Infectious Drugs – also participated in the event. In addition, the Congress brought together representatives of leading pharmaceutical enterprises in Kazakhstan.

The 2nd International Congress and Exhibition “Pharma Kazakhstan and Central Asia” serves as a unique professional international platform for leaders of the pharmaceutical industry from Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and other countries. The event involves heads of investment projects, major enterprises, government authorities, regulatory bodies, technology licensors, developers, manufacturers and suppliers of equipment, engineering and construction companies, as well as providers of technologies and services.

The Congress is dedicated to discussing major investment projects for the construction and modernization of production facilities, as well as exploring opportunities to increase the efficiency of existing pharmaceutical manufacturing enterprises.